Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Frontiers in Immunology|August 16, 2021
Crosstalk Between Tumor-Associated Microglia/Macrophages and CD8-Positive T Cells Plays a Key Role in GlioblastomaSheng Tu, Xu Lin, Jili Qiu, et al.
Molecular Carcinogenesis|June 6, 2023
Potentially functional genetic variants in RPS6KA4 and MAP2K5 in the MAPK signaling pathway predict HBV-related hepatocellular carcinoma survivalMoqin Qiu, Qiuling Lin, Yingchun Liu, et al.
BMC Cancer|May 20, 2026
Real-world outcomes of CDK4/6 inhibitors in combination with endocrine therapy as first-line treatment for HR-positive/HER2-negative advanced breast cancer: multicenter evidence from ChinaXianan Guo, Panni Li, Shiyao Hu, et al.
Frontiers in Oncology|January 21, 2026
Management of malignant breast phyllodes tumor with rib invasion during pregnancy: a rare case report and literature reviewSijie Yu, Panni Li, Wenwen Wu, et al.
NPJ Breast Cancer|July 19, 2022
Functional assessment of missense variants of uncertain significance in the cancer susceptibility gene PALB2Shijie Wu, Lina Qi, Huihui Chen, et al.
Biochemical and Biophysical Research Communications|November 9, 2025
Investigating the anti-atherosclerotic mechanisms of Panax notoginseng saponins through integrated cell experiments, online preparative high-performance liquid chromatography, network pharmacology, molecular docking, and molecular dynamics simulationsWeiye Zhang, Yunxiang Zhou, Yi Cui, et al.
Frontiers in Immunology|November 10, 2022
A novel risk score based on immune-related genes for hepatocellular carcinoma as a reliable prognostic biomarker and correlated with immune infiltrationMeiying Long, Zihan Zhou, Xueyan Wei, et al.
Oncotargets and Therapy|November 29, 2023
Predictive Significance of Systemic Immune-Inflammation Index in Patients with Breast Cancer: A Retrospective Cohort StudyYunxiang Zhou, Xianan Guo, Lu Shen, et al.
Frontiers in Immunology|May 4, 2026
Revisiting the standard of care for immune checkpoint inhibitors in early-stage triple-negative breast cancer: timing, duration, dose, combination, and patient selectionXi Guo, Panni Li, Wei Wu, et al.
Food Chemistry|September 16, 2025
Separation, characterization, AI screening, and bioactivities of marine bioactive peptides: A reviewYi Cui, Xiaorui Li, Yiran Sun, et al.
Pageof 6